ReviewCurrent gastroenterology reports2025
Pancreatic Cystic Lesions in the Older Patient: A Review of Clinical Guidelines and Management.
Review in Current gastroenterology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pancreatic Cystic Lesions: From Basic Knowledge to Recent Guidelines.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThe purpose of this review is to summarize key features of the epidemiology of pancreatic cystic lesions (PCLs), highlight the most common PCLs encountered in clinical practice, review relevant guideline recommendations, and briefly introduce innovative new diagnostic and therapeutic technologies in the field, particularly as they relate to the care of elderly patients. RECENT
findingsWhile CT and MRI are mainstays of diagnostic studies for PCLs, endoscopic ultrasound with fine-needle aspiration and cyst fluid analysis can considerably improve the accuracy of presurgical diagnosis. Surgical interventions remain associated with considerable morbidity. While surveillance of certain lesions is appropriate, surveillance is associated with considerable monetary costs and can cause undue anxiety for patients. There remains uncertainty regarding the optimal management strategy of PCLs given the lack of high-quality evidence to guide recommendations. Management decisions for PCLs, be it for surveillance, surgical resection, or invasive diagnostics, should be highly personalized and based on the unique risk-benefit analysis for a given lesion. Especially in elderly populations, physicians should have informed conversations with patients regarding the likelihood of a given PCL meaningfully affecting quality-of-life or life-expectancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.